5 Dividend Stocks With High Yields That Are Safer Than You Might Think
Pfizer (NYSE: PFE) has a huge 5.9% dividend yield, which is a clear sign that investors are worried about the dividend's sustainability. That's just one of a handful of companies where the same statement can be made across multiple industries. Here's why the risk may not be as big as it seems with high-yielders Pfizer, Bristol Myers Squibb (NYSE: BMY) , Realty Income (NYSE: O) , W.P. Carey (NYSE: WPC) , and Hormel Foods (NYSE: HRL) . There's no question that Pfizer and Bristol Myers Squibb are under pressure today. And there's a good reason, as both of these pharmaceutical companies have patent expirations coming up. They are working on new drugs to offset the expected revenue decline, but sometimes innovation and patent expirations don't align perfectly. This is why Pfizer's yield is 5.9%, and Bristol Myers Squibb's is 4%. The average drug stock yield is 1.3%. Image source: Getty Images. Continue reading